During the past decade, Krankenhaus Dresden-Friedrichstadt conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 10 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenhaus Dresden-Friedrichstadt" #1 sponsor was "Biotronik SE & Co. KG" with 6 trials, followed by "Boehringer Ingelheim" with 6 trials sponsored, "GWT-TUD GmbH" with 3 trials sponsored, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 3 trials sponsored and "Bayer" with 3 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Dresden-Friedrichstadt" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "German Federal Ministry of Education and Research" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "B. Braun Melsungen AG" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus Dresden-Friedrichstadt" are "Atrial Fibrillation" (4 trials), "Heart Failure" (4 trials), "Septic Shock" (3 trials), "Severe Sepsis" (3 trials) and "Chronic Heart Failure" (2 trials). Many other conditions were trialed in "Krankenhaus Dresden-Friedrichstadt" in a lesser frequency.

Most popular intervention types in "Krankenhaus Dresden-Friedrichstadt" are "Drug" (33 trials), "Device" (10 trials), "Procedure" (7 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Empagliflozin" (3 trials), "radiation therapy" (3 trials), "Apixaban" (2 trials) and "Aspirin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus Dresden-Friedrichstadt" are 52 trials for "All" genders.

Currently, there are NaN active trials in "Krankenhaus Dresden-Friedrichstadt". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Krankenhaus Dresden-Friedrichstadt, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus Dresden-Friedrichstadt, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".